<?xml version='1.0' encoding='utf-8'?>
<document id="25989906"><sentence text="Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus."><entity charOffset="16-34" id="DDI-PubMed.25989906.s1.e0" text="hydroxychloroquine" /></sentence><sentence text="Blood concentrations of hydroxychloroquine (HCQ) vary widely among patients with systemic lupus erythematosus (SLE)"><entity charOffset="24-42" id="DDI-PubMed.25989906.s2.e0" text="hydroxychloroquine" /><entity charOffset="44-47" id="DDI-PubMed.25989906.s2.e1" text="HCQ" /><pair ddi="false" e1="DDI-PubMed.25989906.s2.e0" e2="DDI-PubMed.25989906.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25989906.s2.e0" e2="DDI-PubMed.25989906.s2.e1" /></sentence><sentence text=" A pharmacokinetic/pharmacodynamic relationship has been found in different situations, and a very low blood concentration of HCQ is a simple marker of nonadherence to treatment"><entity charOffset="126-128" id="DDI-PubMed.25989906.s3.e0" text="HCQ" /></sentence><sentence text=" Therefore, interest in blood HCQ concentration measurement has increased, but little is known about factors that influence blood HCQ concentration variability"><entity charOffset="30-32" id="DDI-PubMed.25989906.s4.e0" text="HCQ" /><entity charOffset="130-132" id="DDI-PubMed.25989906.s4.e1" text="HCQ" /><pair ddi="false" e1="DDI-PubMed.25989906.s4.e0" e2="DDI-PubMed.25989906.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25989906.s4.e0" e2="DDI-PubMed.25989906.s4.e1" /></sentence><sentence text=" This study was undertaken to analyze determinants of blood HCQ concentrations"><entity charOffset="60-62" id="DDI-PubMed.25989906.s5.e0" text="HCQ" /></sentence><sentence text="" /><sentence text="We conducted a retrospective analysis of patient data, including data from the Plaquenil Lupus Systemic (PLUS) study, to determine the association of epidemiologic, clinical, and biologic factors with blood HCQ concentrations"><entity charOffset="207-209" id="DDI-PubMed.25989906.s7.e0" text="HCQ" /></sentence><sentence text=" Data for nonadherent patients (blood HCQ concentration &lt;200 ng/ml) were excluded"><entity charOffset="38-40" id="DDI-PubMed.25989906.s8.e0" text="HCQ" /></sentence><sentence text="" /><sentence text="To examine homogeneous pharmacologic data, we restricted the analyses of the PLUS data to the 509 SLE patients receiving 400 mg/day" /><sentence text=" We found no association of ethnicity or smoking with blood HCQ concentrations and no pharmacokinetic drug-drug interaction with antacids or with inhibitors or inducers of cytochrome P450 enzymes"><entity charOffset="60-62" id="DDI-PubMed.25989906.s11.e0" text="HCQ" /></sentence><sentence text=" On multivariate analysis, high body mass index (P = 0" /><sentence text="008), no treatment with corticosteroids (P = 0"><entity charOffset="24-39" id="DDI-PubMed.25989906.s13.e0" text="corticosteroids" /></sentence><sentence text="04), increased time between the last tablet intake and measurement of blood HCQ concentrations (P = 0"><entity charOffset="76-90" id="DDI-PubMed.25989906.s14.e0" text="HCQ" /></sentence><sentence text="017), low platelet count (P &lt; 0" /><sentence text="001), low neutrophil count (P &lt; 0" /><sentence text="001), and high estimated creatinine clearance (P &lt; 0"><entity charOffset="25-35" id="DDI-PubMed.25989906.s17.e0" text="creatinine" /></sentence><sentence text="001) were associated with low blood HCQ concentrations"><entity charOffset="36-45" id="DDI-PubMed.25989906.s18.e0" text="HCQ" /></sentence><sentence text=" In 22 SLE patients with chronic renal insufficiency (median serum creatinine clearance 52 ml/minute [range 23-58 ml/minute]) who received 400 mg/day HCQ, the median blood HCQ concentration was significantly higher than that in the 509 patients from the PLUS study (1,338 ng/ml [range 504-2,229 ng/ml] versus 917 ng/ml [range 208-3316 ng/ml]) (P &lt; 0"><entity charOffset="67-77" id="DDI-PubMed.25989906.s19.e0" text="creatinine" /><entity charOffset="150-159" id="DDI-PubMed.25989906.s19.e1" text="HCQ" /><entity charOffset="172-181" id="DDI-PubMed.25989906.s19.e2" text="HCQ" /><pair ddi="false" e1="DDI-PubMed.25989906.s19.e0" e2="DDI-PubMed.25989906.s19.e0" /><pair ddi="false" e1="DDI-PubMed.25989906.s19.e0" e2="DDI-PubMed.25989906.s19.e1" /><pair ddi="false" e1="DDI-PubMed.25989906.s19.e0" e2="DDI-PubMed.25989906.s19.e2" /><pair ddi="false" e1="DDI-PubMed.25989906.s19.e1" e2="DDI-PubMed.25989906.s19.e1" /><pair ddi="false" e1="DDI-PubMed.25989906.s19.e1" e2="DDI-PubMed.25989906.s19.e2" /></sentence><sentence text="001)" /><sentence text="" /><sentence text="We provide a comprehensive analysis of determinants of blood HCQ concentrations"><entity charOffset="61-63" id="DDI-PubMed.25989906.s22.e0" text="HCQ" /></sentence><sentence text=" Because this measurement is increasingly being used, these data might be useful for clinicians" /><sentence text="" /></document>